Most people with type 2 diabetes can fast for 16 hours, and research suggests it may actually improve blood sugar control. But safety depends heavily on which medications you take, because some diabetes drugs create real risks during a fasting window. The 16:8 method (fasting 16 hours, eating within 8) is the most commonly studied form of time-restricted eating, and the evidence for its metabolic benefits in type 2 diabetes is growing. Type 1 diabetes requires more caution, though fasting isn’t automatically off the table.
What 16-Hour Fasting Does to Blood Sugar
When you fast for 16 hours, your body shifts from using recently eaten food for energy to drawing on stored glucose and fat. For people with type 2 diabetes, this shift appears to improve how the body responds to insulin, not just because of weight loss, but through changes in metabolic timing itself. A study of men with prediabetes found that restricting eating to an early window led to significant drops in fasting insulin levels and improvements in insulin sensitivity, even though blood sugar and body weight stayed roughly the same. The act of aligning meals with the body’s circadian rhythm seems to independently benefit carbohydrate metabolism.
A randomized trial comparing two fasting schedules (16:8 and 14:10, used three days per week for three months) found that both led to a meaningful reduction in fasting glucose, about 30 mg/dL on average, along with a half-point drop in HbA1c. That HbA1c reduction is comparable to what some oral diabetes medications achieve. A larger network analysis of 13 randomized trials involving 867 people with type 2 diabetes confirmed that all forms of intermittent fasting outperformed standard diets for glucose control and insulin sensitivity.
The Hypoglycemia Risk Is Real
The main danger of fasting with diabetes is your blood sugar dropping too low. A randomized controlled trial found that intermittent fasting roughly doubled the rate of hypoglycemia in people with type 2 diabetes who were on blood sugar-lowering medications. That said, when participants received proper education and had their medication doses reduced beforehand, the actual number of low blood sugar episodes was fewer than researchers expected, averaging 1.4 events over 12 weeks.
The risk isn’t equal across all medications. Drugs that directly stimulate insulin release, like sulfonylureas, are the most likely to push your blood sugar dangerously low during a fast. Insulin itself carries the same risk. If you take either of these, fasting without a dose adjustment is not safe. Other medications, like metformin, carry a much lower hypoglycemia risk on their own and generally don’t need to be changed for a 16-hour fast.
SGLT2 Inhibitors and Ketoacidosis
One medication class deserves special attention. SGLT2 inhibitors (medications ending in “-flozin,” such as empagliflozin, dapagliflozin, and canagliflozin) work by causing your kidneys to excrete excess glucose. When combined with fasting, they can trigger a rare but serious condition called euglycemic ketoacidosis, where dangerous acid levels build up in the blood even though blood sugar reads normal. Current guidance advises withholding SGLT2 inhibitors during prolonged fasting.
The overall incidence of ketoacidosis from SGLT2 inhibitors is low, roughly 0.1% of patients, but fasting is a recognized trigger. Some estimates suggest these drugs increase ketoacidosis risk sevenfold in people with type 2 diabetes. Because blood sugar may look fine during an episode, the condition can be missed until symptoms like nausea, vomiting, rapid breathing, or unusual fatigue appear. If you take an SGLT2 inhibitor, talk with your prescriber before starting any fasting routine.
How Medications Are Typically Adjusted
Clinical protocols for fasting with insulin-treated type 2 diabetes generally follow a pattern: basal (long-acting) insulin is reduced by about 20% on fasting days, and mealtime (rapid-acting) insulin is skipped entirely during the fast. If blood sugar drops below 70 mg/dL (3.9 mmol/L), the fast is broken immediately, and the basal insulin dose is reduced by another 10% going forward. The target range during a fast is typically 100 to 130 mg/dL (5.6 to 7.2 mmol/L).
These adjustments aren’t something to guess at. The specific reductions depend on your current doses, your typical blood sugar patterns, and which combination of drugs you’re on. This is the part of 16:8 fasting that genuinely requires working with a healthcare provider, especially for the first few weeks while you and your doctor figure out the right dose changes.
Type 1 Diabetes Carries More Risk
Fasting with type 1 diabetes is more complex because you depend entirely on external insulin. Too much insulin during a fast causes hypoglycemia; too little leads to ketoacidosis. That said, small studies have shown that people with type 1 diabetes can fast without developing ketoacidosis when closely monitored, with improvements in fat metabolism and reduced glycemic variability. The margin for error is narrow, though, and continuous glucose monitoring becomes essential rather than optional. Most of the positive research on 16-hour fasting and diabetes focuses on type 2.
What to Eat When You Break the Fast
How you break a 16-hour fast matters as much as the fast itself. A randomized crossover study in people with type 2 diabetes compared a carbohydrate-containing breakfast to one with no carbohydrates after an overnight fast. The no-carbohydrate meal produced a significantly lower glucose spike: peak blood sugar was about 1.9 mmol/L (roughly 34 mg/dL) lower over the five hours after the meal. Time spent with elevated blood sugar above 180 mg/dL dropped from 26% to 11%.
In practical terms, this means breaking your fast with protein and healthy fats, things like eggs, avocado, nuts, or cheese, rather than toast, cereal, or fruit juice. The lunch meal later in the day wasn’t affected by what people ate at breakfast, so this isn’t about restricting carbohydrates all day. It’s specifically about that first meal, when your body is most sensitive to a glucose surge after hours without food.
Who Should Be More Cautious
Not everyone with diabetes faces the same level of risk during a 16-hour fast. The people who need the most preparation and monitoring include those who take insulin (basal, bolus, or both), those on sulfonylureas, those on SGLT2 inhibitors, and anyone with a history of severe hypoglycemia or hypoglycemia unawareness (where you don’t feel symptoms when your blood sugar drops). People with diabetes-related kidney disease also need closer attention, since dehydration during fasting can worsen kidney function.
On the other hand, people with type 2 diabetes managed through diet alone, or with metformin only, face relatively low risk from a 16-hour eating window. For many in this group, 16:8 fasting can be started with basic blood sugar monitoring and attention to hydration during fasting hours. Water, black coffee, and unsweetened tea don’t break a fast and help prevent dehydration, which can independently raise blood sugar.